Physician profile
Alice Haijie Xiang
NPI 1740842558
$3,311.55
in general payments reported to CMS, 2019-2025
18 companies · $794 in 2025
The $794 reported for 2025 was more than what 88% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $108 · 2021: $350 · 2022: $597 · 2023: $989 · 2024: $169 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212 · Travel and Lodging: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.57 |
| Travel and Lodging | $740.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,080.67 | 2019-2024 | Lithovue, Spaceoar Vue System - 10ml, Ams 700 |
| Teleflex LLC | $958.36 | 2022-2025 | Urolift, Deflux Metal Needle |
| Medtronic, INC. | $228.94 | 2021-2023 | Interstim |
| Janssen Scientific Affairs, LLC | $155.32 | 2022-2024 | Erleada |
| Coloplast Corp | $154.50 | 2021 | |
| Urogen Pharma, INC. | $125.21 | 2023 | Jelmyto |
| Astrazeneca Pharmaceuticals Lp | $117.94 | 2022-2023 | |
| Photocure INC | $107.92 | 2020 | |
| Procept Biorobotics Corporation | $102.52 | 2019 | |
| Janssen Biotech, INC. | $61.96 | 2023-2024 | Erleada |
| Medtronic USA, INC. | $56.20 | 2019 | |
| Astellas Pharma US INC | $42.83 | 2023 | |
| Dendreon Pharmaceuticals LLC | $24.03 | 2019 | |
| Accord Healthcare, INC. | $21.99 | 2023 | |
| Tolmar, INC. | $20.39 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $19.80 | 2023 | |
| Axonics, INC. | $17.49 | 2022 | |
| Endo Pharmaceuticals INC. | $15.48 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Xiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.